BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 15689192)

  • 1. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack.
    Juhasz G; Zsombok T; Jakab B; Nemeth J; Szolcsanyi J; Bagdy G
    Cephalalgia; 2005 Mar; 25(3):179-83. PubMed ID: 15689192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumatriptan causes parallel decrease in plasma CGRP concentration and migraine headache during nitroglycerin-induced migraine attack.
    Vanmolkot F; Van der Schueren B; de Hoon J
    Cephalalgia; 2006 Aug; 26(8):1037-8; author reply 1038-9. PubMed ID: 16886948
    [No Abstract]   [Full Text] [Related]  

  • 3. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release.
    Juhasz G; Zsombok T; Modos EA; Olajos S; Jakab B; Nemeth J; Szolcsanyi J; Vitrai J; Bagdy G
    Pain; 2003 Dec; 106(3):461-470. PubMed ID: 14659530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.
    Kruuse C; Iversen HK; Jansen-Olesen I; Edvinsson L; Olesen J
    Cephalalgia; 2010 Apr; 30(4):467-74. PubMed ID: 19673898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.
    Kruuse C; Frandsen E; Schifter S; Thomsen LL; Birk S; Olesen J
    Cephalalgia; 2004 Jul; 24(7):547-53. PubMed ID: 15196297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL; Cady RK; Durham PL
    Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sumatriptan on capsaicin-induced carotid haemodynamic changes and CGRP release in anaesthetized pigs.
    Arulmani U; Heiligers JP; Garrelds IM; Sánchez-López A; Willems EW; Villalón CM; Saxena PR
    Cephalalgia; 2004 Sep; 24(9):717-27. PubMed ID: 15315527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of autogenic training on nitroglycerin-induced headaches.
    Juhasz G; Zsombok T; Gonda X; Nagyne N; Modosne E; Bagdy G
    Headache; 2007 Mar; 47(3):371-83. PubMed ID: 17371354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No increase of calcitonin gene-related peptide in jugular blood during migraine.
    Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
    Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].
    Stepień A; Jagustyn P; Trafny EA; Widerkiewicz K
    Neurol Neurochir Pol; 2003; 37(5):1013-23. PubMed ID: 15174248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroglycerin facilitates calcitonin gene-related peptide-induced behavior.
    Yao D; Sessle BJ
    Neuroreport; 2008 Aug; 19(13):1307-11. PubMed ID: 18695513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine levels in the jugular venous blood of migraine without aura patients during attacks.
    Sarchielli P; Alberti A; Vaianella L; Pierguidi L; Floridi A; Mazzotta G; Floridi A; Gallai V
    Headache; 2004; 44(10):961-8. PubMed ID: 15546258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
    Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
    Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype.
    Hansen JM; Thomsen LL; Olesen J; Ashina M
    Neurology; 2008 Sep; 71(11):841-7. PubMed ID: 18779512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
    Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
    Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
    McCrory P; Heywood J; Ugoni A
    Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a vascular factor in migraine.
    Asghar MS; Hansen AE; Amin FM; van der Geest RJ; Koning Pv; Larsson HB; Olesen J; Ashina M
    Ann Neurol; 2011 Apr; 69(4):635-45. PubMed ID: 21416486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack.
    Fanciullacci M; Alessandri M; Figini M; Geppetti P; Michelacci S
    Pain; 1995 Feb; 60(2):119-123. PubMed ID: 7540279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.